Abstract
BackgroundNatural killer (NK) cells play a key role in antibody dependent cellular cytotoxicity (ADCC) via their CD16 Fc receptor. NK cell therapies can be targeted to tumors via tumor specific...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
